4-氯苯乙酸

ClC₆H₄CH₂CO₂H

170.59

1072816

217-521-6

MFCD00004344

24848401

NA.22

4-Chlorophenylacetic acid possess anticancer properties. It is a novel therapeutic agent which can be useful in prevention or treatment of estrogen-sensitive breast cancer. It acts as carbon and energy supplement and is degraded by Pseudomonas sp. strain CBS3.

4-Chlorophenylacetic acid was used to study the mechanism of aerobic degradation of 1,1-dichloro-2,2-bis(4-chlorophenyl)ethane by Ralstonia eutropha A5.

Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. 139262.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

ReagentPlus is a registered trademark of sigma-aldrich Co. LLC

ReagentPlus^®

100

99%

102-105 ℃ (lit.)

ethanol: soluble 100 mg/mL, clear, faintly yellow

OC(=O)Cc1ccc(Cl)cc1

1S/C8H7ClO2/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4H,5H2,(H,10,11)

CDPKJZJVTHSESZ-UHFFFAOYSA-N

10, 100 g in poly bottle

GHS07

Warning

H312 + H332

P280 - P302 + P352 + P312 - P304 + P340 + P312

Acute Tox. 4 Dermal

11 - Combustible Solids

WGK 3

dust mask type N95 (US), Eyeshields, Gloves